RIFAXIMIN HAS NO EFFECT ON REBLEEDING IN CIRRHOTIC PORTAL HYPERTENSION-AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL

被引:0
|
作者
Huang, Xiaoquan
Liu, Chengfeng
Li, Feng
Chen, Shiyao
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1563
引用
收藏
页码:S1252 / S1252
页数:1
相关论文
共 50 条
  • [31] A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska
    Gessner, BD
    Baggett, HC
    Muth, PT
    Dunaway, E
    Gold, BD
    Feng, ZD
    Parkinson, AJ
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (04): : 537 - 546
  • [32] Prophylactic Effect of Erythropoietin Injection to Prevent Acute Mountain Sickness: An Open-Label Randomized Controlled Trial
    Heo, Kyoung
    Kang, Joong Koo
    Choi, Chang Min
    Lee, Moo Song
    Noh, Kyoung Woo
    Kim, Soon Bae
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (03) : 416 - 422
  • [33] Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial
    Preston, Ioana R.
    Burger, Charles D.
    Bartolome, Sonja
    Safdar, Zeenat
    Krowka, Michael
    Sood, Namita
    Ford, Hubert J.
    Battarjee, Wejdan F.
    Chakinala, Murali M.
    Gomberg-Maitland, Mardi
    Hill, Nicholas S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (05): : 464 - 472
  • [34] Treatment for Resistant Hypertension Under the Guidance of Pharmacogenomics: A Randomised Controlled Open-Label Trial
    Wang, Ai
    Mbikyo, Muisha Bienvenue
    Zhang, Junzhe
    Cui, Nan
    Li, Zhao
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (04): : 383 - 389
  • [35] Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial
    Kimer, Nina
    Pedersen, Julie S.
    Busk, Troels M.
    Hobolth, Lise
    Gluud, Lise L.
    Krag, Aleksander
    Moller, Soren
    Bendtsen, Flemming
    HEPATOLOGY, 2016, 64 : 1041A - 1041A
  • [36] Reply to the letter to Editor on comparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial
    Sanjeev Kumar Jha
    Manish Mishra
    Ashish Jha
    Vishwa Mohan Dayal
    Indian Journal of Gastroenterology, 2018, 37 (6) : 565 - 566
  • [37] Reply to the letter to Editor oncomparison of continuous versus intermittent infusions of terlipressin for the control of acute variceal bleeding in patients with portal hypertension: An open-label randomized controlled trial
    Jha, Sanjeev Kumar
    Mishra, Manish
    Jha, Ashish
    Dayal, Vishwa Mohan
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2018, 37 (06) : 565 - 566
  • [38] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, Uri
    Carmeli, Gal
    Chalamish, Yossi
    Braw, Yoram
    Kirsch, Irving
    Shefet, Daphna
    Krieger, Israel
    Mendlovic, Shlomo
    Bloch, Yuval
    Lichtenberg, Pesach
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 707 - 710
  • [39] Open-label placebo treatment in chronic low back pain: a randomized controlled trial
    Carvalho, Claudia
    Caetano, Joaquim Machado
    Cunha, Lidia
    Rebouta, Paula
    Kaptchuk, Ted J.
    Kirsch, Irving
    PAIN, 2016, 157 (12) : 2766 - 2772
  • [40] Role of doxycycline in the treatment of dengue infection: An open-label, randomized, controlled, pilot trial
    Kumar, Banothu Vinod
    Kamboj, Kajal
    Pannu, Ashok Kumar
    Yadav, Ashok Kumar
    Bhatia, Mandip
    Saroch, Atul
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2024, 17 (04) : 160 - 165